Study evaluates the use of tirzepatide in overweight/obese a

A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes.

Related Keywords

United States , Satish Garg , Mary Ann Liebert Inc , University Of Colorado Denver , Diabetes Technology Therapeutics , Ann Liebert , Diabetes Technology , Colorado Denver , Western Europe , Diabetes , Efficacy , Type 1 Diabetes , Cardiovascular Disease , Drug Delivery , Drugs , Glucose , Ba1c , Insulin , Research , Software , Technology , Herapeutics , Type 2 Diabetes , Weight Loss ,